No black box warning on record for Ondansetron Hcl

As of the latest FDA labeling reviewed, Ondansetron Hcl (ONDANSETRON HCL) does not carry a black box warning. Standard warnings and precautions still apply — see the full Ondansetron Hcl medicine page for the complete safety profile.

Other warnings & precautions

5. Warnings and Precautions 5.1 Hypersensitivity Reactions Hypersensitivity reactions, including anaphylaxis and bronchospasm, have been reported in patients who have exhibited hypersensitivity to other selective 5-HT3 receptor antagonists. If hypersensitivity reactions occur, discontinue use of ondansetron; treat promptly per standard of care and monitor until signs and symptoms resolve [see Cont

No black box warning on record for Ondansetron Hcl

Other warnings & precautions

5. Warnings and Precautions 5.1 Hypersensitivity Reactions Hypersensitivity reactions, including anaphylaxis and bronchospasm, have been reported in patients who have exhibited hypersensitivity to other selective 5-HT3 receptor antagonists. If hypersensitivity reactions occur, discontinue use of ondansetron; treat promptly per standard of care and monitor until signs and symptoms resolve [see Cont

Ondansetron Hcl Black Box Warning

No black box warning on record for Ondansetron Hcl

Other warnings & precautions

Ondansetron Hcl Black Box Warning

No black box warning on record for Ondansetron Hcl

Other warnings & precautions